Ariela Arad

600 total citations
21 papers, 338 citations indexed

About

Ariela Arad is a scholar working on Genetics, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Ariela Arad has authored 21 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Hematology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Ariela Arad's work include Chronic Lymphocytic Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Ariela Arad is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Ariela Arad collaborates with scholars based in Israel, United States and Netherlands. Ariela Arad's co-authors include Valérie Proulle, Bruce Furie, Richard Furie, Barbara C. Furie, Yosef Kalish, Amihai Rottenstreich, Bruria Hirsh Raccah, Daniel Mimouni, Avraham Zeharia and Dan Ben Amitai and has published in prestigious journals such as Nature Communications, Blood and Cancers.

In The Last Decade

Ariela Arad

19 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ariela Arad Israel 8 105 95 80 74 60 21 338
M. Le Besnerais France 11 54 0.5× 89 0.9× 35 0.4× 32 0.4× 48 0.8× 23 290
Hélène Maillard France 14 78 0.7× 196 2.1× 48 0.6× 114 1.5× 53 0.9× 48 486
Johanna Gebhart Austria 14 362 3.4× 109 1.1× 101 1.3× 41 0.6× 57 0.9× 53 527
Weerapat Owattanapanich Thailand 12 236 2.2× 96 1.0× 175 2.2× 43 0.6× 78 1.3× 72 560
Selma Yazıcı Türkiye 9 82 0.8× 110 1.2× 30 0.4× 48 0.6× 35 0.6× 16 447
Sabine Mainbourg France 10 45 0.4× 110 1.2× 78 1.0× 28 0.4× 33 0.6× 31 494
Vera Ortiz-Santamaría Spain 11 126 1.2× 268 2.8× 36 0.5× 108 1.5× 67 1.1× 30 522
S. Miranda France 12 82 0.8× 131 1.4× 21 0.3× 31 0.4× 29 0.5× 32 379
Bülent Ündar Türkiye 12 215 2.0× 49 0.5× 101 1.3× 49 0.7× 39 0.7× 51 407
Agnieszka Padjas Poland 11 69 0.7× 158 1.7× 17 0.2× 29 0.4× 53 0.9× 24 328

Countries citing papers authored by Ariela Arad

Since Specialization
Citations

This map shows the geographic impact of Ariela Arad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ariela Arad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ariela Arad more than expected).

Fields of papers citing papers by Ariela Arad

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ariela Arad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ariela Arad. The network helps show where Ariela Arad may publish in the future.

Co-authorship network of co-authors of Ariela Arad

This figure shows the co-authorship network connecting the top 25 collaborators of Ariela Arad. A scholar is included among the top collaborators of Ariela Arad based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ariela Arad. Ariela Arad is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Aizer, Adva, Ariela Arad, Jigal Haas, et al.. (2025). The outcomes of blastocyst versus cleavage stage embryo biopsy for preimplantation genetic testing for monogenic diseases. Frontiers in Endocrinology. 16. 1518760–1518760. 1 indexed citations
4.
Aumann, Shlomzion, Vladimir Vainstein, Ariela Arad, et al.. (2024). DNMT3A, TET2, and ASXL1 (DTA) Mutations Are Associated with Thrombosis and Bleeding in Patients with Myeloproliferative Neoplasms. Blood. 144(Supplement 1). 3189–3189. 1 indexed citations
5.
Moss, Joshua, Roni Ben‐Ami, Ela Shai, et al.. (2023). Megakaryocyte- and erythroblast-specific cell-free DNA patterns in plasma and platelets reflect thrombopoiesis and erythropoiesis levels. Nature Communications. 14(1). 7542–7542. 17 indexed citations
6.
Leader, Avi, Eva N. Hamulyák, Lisa Baumann Kreuziger, et al.. (2023). OC 54.4 Multinational Cohort Analysis of Intracranial Hemorrhage Outcomes in Patients with Brain Tumors Receiving Anticoagulation (ABC Study). Research and Practice in Thrombosis and Haemostasis. 7. 100611–100611. 2 indexed citations
8.
Rottenstreich, Amihai, Galit Sarig, Yona Nadir, et al.. (2020). Pregnancy and non-pregnancy related immune thrombotic thrombocytopenic purpura in women of reproductive age. Journal of Thrombosis and Thrombolysis. 51(1). 187–193. 4 indexed citations
9.
Tadmor, Tamar, Andrei Braester, Najib Dally, et al.. (2019). A new risk model to predict time to first treatment in chronic lymphocytic leukemia based on heavy chain immunoparesis and summated free light chain. European Journal Of Haematology. 103(4). 335–341. 4 indexed citations
10.
Joffe, Erel, Neta Goldschmidt, Osnat Bairey, et al.. (2018). Outcomes of second‐line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials. European Journal Of Haematology. 101(3). 399–406. 5 indexed citations
11.
Rottenstreich, Amihai, et al.. (2018). Antiphospholipid antibody profile-based outcome of purely vascular and purely obstetric antiphospholipid syndrome. Journal of Thrombosis and Thrombolysis. 46(2). 166–173. 6 indexed citations
12.
Rottenstreich, Amihai, et al.. (2017). Implementation of an institutional protocol to improve inferior vena cava utilization and outcomes. Journal of Thrombosis and Thrombolysis. 44(2). 190–196. 3 indexed citations
13.
Rottenstreich, Amihai, et al.. (2017). The effect of bariatric surgery on direct-acting oral anticoagulant drug levels. Thrombosis Research. 163. 190–195. 46 indexed citations
14.
Grisariu, Sigal, Iuliana Vaxman, Moshe E. Gatt, et al.. (2016). Enteroviral infection in patients treated with rituximab for non‐Hodgkin lymphoma: a case series and review of the literature. Hematological Oncology. 35(4). 591–598. 26 indexed citations
15.
Ofran, Yishai, Ronit Leiba, Chezi Ganzel, et al.. (2015). Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the “3 + 7” induction regimen for acute myeloid leukemia. American Journal of Hematology. 90(12). 1159–1164. 21 indexed citations
16.
Tadmor, Tamar, Lev Shvidel, Neta Goldschmidt, et al.. (2014). Hodgkin's variant of Richter transformation in chronic lymphocytic leukemia; a retrospective study from the Israeli CLL study group.. PubMed. 34(2). 785–90. 32 indexed citations
17.
18.
Arad, Ariela, Valérie Proulle, Richard Furie, Barbara C. Furie, & Bruce Furie. (2011). β2-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model. Blood. 117(12). 3453–3459. 101 indexed citations
20.
Arad, Ariela, Daniel Mimouni, Dan Ben Amitai, Avraham Zeharia, & Marc Mimouni. (1999). Efficacy of Topical Application of Eosin Compared with Zinc Oxide Paste and Corticosteroid Cream for Diaper Dermatitis. Dermatology. 199(4). 319–322. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026